This week, global experts will gather at the University of British Columbia to discuss the latest trends in 3D bioprinting—a technology used to create living tissues and organs. In this Q&A, UBC chemical and biological engineering professor Vikramaditya Yadav, who is also with the Regenerative Medicine Cluster Initiative in B.C., explains how bioprinting could potentially transform healthcare and drug development,…
Read More
PureTech Health plc (“PureTech Health” or the “Company”, LSE:PRTC), an advanced, clinical-stage biopharmaceutical company, is pleased to announce a licensing agreement between Commense, Inc. (“Commense”), a subsidiary of PureTech Health, and the University of British Columbia (“UBC”) for a microbiome-based therapy directed toward the prevention of asthma and other allergic diseases that present in childhood. This live biotherapeutic product bolsters…
Read More
Leading HIV/AIDS researcher Julio Montaner is among a group of scientists, writers, doctors and researchers receiving a prestigious prize for brilliant work in fields including health sciences, engineering and humanities. The Argentine-Canadian is among five scholars awarded this year’s Killam Prize, which honours Canadian researchers and scientists whose lifetime of work has impacted Canadians and citizens around the world. Each…
Read More
The federal science minister says universities aren’t doing the heavy lifting to appoint more female research chairs, so she wants to force their hands. On her way to give a speech Wednesday to university presidents in Montreal, Kirsty Duncan was handed the latest statistics on the number of men and women among applicants for new Canada Research Chair positions. “They’re…
Read More
Scientists at the Wellcome Trust Sanger Institute and their collaborators at the University of British Columbia have created an innovative technique for studying how chlamydia interacts with the human immune system. Researchers used a combination of gene editing and stem cell technologies to make the model. The team identified two genes from our immune system, IRF5 and IL-10RA as key…
Read More
Working with a shared voice can be very effective for improving outcomes in the Movement Disorders clinic, finds Dr. Martin McKeown and Parkinson’s research coordinator Kristen Sundvick. For some people with Parkinson’s disease (PD), even optimal drug treatments simply aren’t as effective as they need to be. On conventional medication, people may fluctuate unpredictably between being unable to move, to…
Read More
People with multiple sclerosis can show signs of something wrong five years before the onset of disease, much earlier than previously thought, according to a new analysis of health records from people with the condition. The new research, published today in Lancet Neurology, is a first step to identifying red flags to help doctors screen for the disease and start…
Read More
A drug created from a malaria protein stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments. “This is the first study where we put the concept of using malaria proteins for cancer therapy into a direct clinical context,” said Mads Daugaard, an assistant professor of urologic science at the University of British…
Read More
 DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced a proposed registered public offering of its common stock and warrants to purchase common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering…
Read More